Welcome to our dedicated page for Exponent news (Ticker: EXPO), a resource for investors and traders seeking the latest updates and insights on Exponent stock.
Exponent Inc. (Nasdaq: EXPO) is a leading engineering and scientific consulting firm dedicated to providing solutions to complex issues faced by various industries. The company operates through a highly multidisciplinary organization comprising scientists, physicians, engineers, and business consultants, bringing together over 90 technical disciplines. With a presence in 20 offices across the United States and 6 international locations, Exponent is committed to delivering unparalleled technical expertise.
Core Business and Services: Exponent operates through two main segments: Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment, which accounts for the majority of Exponent's revenue, focuses on services such as biomechanics, biomedical engineering, civil engineering, and construction consulting. The Environmental and Health segment addresses chemical regulation, food safety, ecological and biological sciences, and environmental and earth sciences.
Latest Achievements: Exponent recently reported a 5% increase in total revenues for the third quarter of 2023, highlighting its adaptability and diversified portfolio. The company also announced a quarterly cash dividend of $0.26 per share to be paid in December 2023 and has continued its commitment to return value to shareholders through dividends and stock repurchases.
Recent Projects: The firm is actively engaged in failure analysis and dispute-related work across multiple sectors, including consumer electronics, transportation, and energy. It has also been involved in regulatory consulting services for the chemical industry and in providing safety-related evaluations.
Financial Condition: Exponent's financial results for the first three quarters of 2023 include a 7% increase in total revenues to $413.9 million. The company closed the period with $137.1 million in cash and cash equivalents, indicating robust financial health.
Partnerships and Collaborations: Exponent collaborates with a wide range of clients, including multinational corporations, startups, law firms, insurance companies, and government agencies. This diverse client base underscores the firm's ability to address a variety of complex challenges.
In summary, Exponent Inc. continues to leverage its deep technical expertise and multidisciplinary approach to address the evolving needs of modern industries, ensuring long-term growth and value creation for its stakeholders.
Exponent, Inc. (Nasdaq:EXPO) announced that its Q2 fiscal year 2022 financial results will be disclosed post-market on July 28, 2022. The company will host a conference call and webcast at 4:30 p.m. ET to discuss the results, featuring Dr. Catherine Corrigan and Richard Schlenker. A telephonic replay will be available until August 4, 2022. Exponent is recognized for its interdisciplinary consulting services, offering solutions across over 90 technical disciplines and leveraging 50 years of experience in complex problem-solving.
Exponent, Inc. (Nasdaq:EXPO) announced that Dr. Catherine Corrigan and Richard Schlenker will present at two upcoming investor conferences. The Berenberg Conference USA 2022 is scheduled for May 25, 2022, from 10:15am to 11:00am ET, followed by the Stifel Cross Sector Insight Conference 2022 on June 8, 2022, from 1:15pm to 1:45pm ET. A webcast of the presentations will be available on Exponent’s investor relations page, with an archived replay accessible afterward.
Exponent, Inc. (Nasdaq: EXPO) announced a quarterly cash dividend of $0.24 per share, payable on June 24, 2022, to stockholders of record as of June 10, 2022. The firm confirmed its commitment to continuing quarterly dividends each year in March, June, September, and December. Dr. Catherine Corrigan, President and CEO, noted that this dividend reflects the strength of the company's balance sheet and business model, aimed at generating long-term shareholder value.
Exponent, Inc. (Nasdaq: EXPO) reported a 10.3% increase in total revenues for Q1 2022, reaching $128.5 million year-over-year, alongside a decrease in net income to $29.6 million or $0.56 per diluted share. EBITDA grew to $34.5 million, representing 29.2% of net revenues. The company anticipates mid-single digit growth for Q2 revenues and mid- to high-single digit growth for the full year 2022. Exponent continues to focus on expanding its engineering and scientific services across various sectors, particularly in consumer electronics and life sciences.
Exponent, Inc. (Nasdaq:EXPO) will announce its first quarter of fiscal year 2022 financial results on April 28, 2022, after market close. The conference call will begin at 4:30 p.m. ET, featuring CEO Dr. Catherine Corrigan and CFO Richard Schlenker. Investors can join the call via phone or through a live webcast available on the company’s investor relations site. Exponent specializes in engineering and scientific consulting, leveraging over 50 years of experience to provide solutions across 90 technical disciplines.
Exponent, Inc. (Nasdaq: EXPO) announced a $150 million expansion of its share repurchase program, increasing total available repurchases to approximately $179.5 million. The firm has repurchased $38.9 million of common stock in fiscal year 2022. CEO Dr. Catherine Corrigan expressed confidence in Exponent’s strategic direction and commitment to delivering shareholder value, noting a recent 20% increase in the quarterly dividend. Exponent ended fiscal 2021 with $297.7 million in cash and cash equivalents, supporting its robust capital allocation strategy.
Exponent, Inc. (Nasdaq: EXPO) reported a robust performance for Q4 and fiscal year 2021, with total revenue increasing 15% year-over-year to $466.3 million. Q4 revenues grew 9.9% to $113.5 million, although net income fell to $20.4 million from $21.8 million. EBITDA rose to $132.3 million, reflecting a 30.4% margin. The company announced an increase in its quarterly cash dividend from $0.20 to $0.24, highlighting strong demand for its engineering and environmental services. Looking ahead, Exponent anticipates mid- to high-single-digit revenue growth for 2022, but expects a decline in EBITDA margin.
Exponent, Inc. (Nasdaq: EXPO) announced a 20% increase in its quarterly dividend from $0.20 to $0.24 per share, payable on March 25, 2022, to shareholders of record by March 11, 2022. In 2021, the company returned $50.2 million to shareholders through dividends and stock repurchases, ending the year with $297.7 million in liquidity. CEO Dr. Catherine Corrigan emphasized the dividend hike reflects strong financial health and business resilience amid economic challenges. Exponent will continue its quarterly dividend payments every March, June, September, and December, subject to board approval.
Exponent, Inc. (Nasdaq:EXPO) will report its fourth quarter and fiscal year 2021 financial results on February 3, 2022, after market close. The announcement will be followed by a conference call hosted by CEO Dr. Catherine Corrigan and CFO Richard Schlenker at 4:30 PM ET. Investors can access the live call via phone or join the webcast from the Investor Relations section of Exponent's website. This call aims to provide insights into the company's financial performance and business developments for the fiscal year.
FAQ
What is the current stock price of Exponent (EXPO)?
What is the market cap of Exponent (EXPO)?
What services does Exponent Inc. offer?
What are Exponent's main business segments?
How has Exponent performed financially recently?
Where is Exponent Inc. located?
Who are Exponent's clients?
What recent projects has Exponent been involved in?
What recent achievements has Exponent announced?
What is Exponent's approach to problem-solving?
How can I contact Exponent Inc.?
What is Exponent's outlook for the future?
